Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Working Party ◽

Brentuximab Vedotin ◽

Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma

Bone Marrow Transplantation ◽

10.1038/s41409-020-0935-0 ◽

2020 ◽

Vol 55 (12) ◽

pp. 2322-2325

Author(s):

Moussab Damlaj ◽

Khadega A. Abuelgasim ◽

Ayman Alhejazi ◽

Bader Alahmari ◽

Ahmed Alaskar ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Brentuximab Vedotin ◽

Classical Hodgkin Lymphoma ◽

Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT

Bone Marrow Transplantation ◽

10.1038/s41409-020-0929-y ◽

2020 ◽

Vol 55 (11) ◽

pp. 2170-2179

Author(s):

Anna Sureda ◽

Sonja Genadieva Stavrik ◽

Ariane Boumendil ◽

Hervé Finel ◽

Irma Khvedelidze ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Working Party ◽

Hematopoietic Stem ◽

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2018.07.115 ◽

2018 ◽

Vol 18 ◽

pp. S233

Author(s):

Moussab Damlaj ◽

Ahmed Alaskar ◽

Bader Alahmari ◽

Samer Ghazi ◽

Ayman Hejazi ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Brentuximab Vedotin ◽

Hematopoietic Stem ◽

08 / Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

10.26226/morressier.5b3b802cb1b87b000eced946 ◽

2018 ◽

Author(s):

Damlaj Moussab

Keyword(s):

Stem Cell ◽

High Risk ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Brentuximab Vedotin ◽

Hematopoietic Stem ◽

BRENTUXIMAB VEDOTIN SALVAGE FOLLOWED BY CONSOLIDATION POST AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HIGH RISK RELAPSED REFRACTORY HODGKIN LYMPHOMA

Hematological Oncology ◽

10.1002/hon.171_2631 ◽

2019 ◽

Vol 37 ◽

pp. 492-494

Author(s):

M. Damlaj ◽

A. Alaskar ◽

G. Gmati ◽

K. Abuelgasim ◽

B. Alahmari ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Brentuximab Vedotin ◽

Hematopoietic Stem ◽

Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors: Feasibility and safety

European Journal Of Haematology ◽

10.1111/ejh.13186 ◽

2018 ◽

Vol 102 (2) ◽

pp. 150-156 ◽

Cited By ~ 5

Author(s):

Reyad Dada ◽

Binyam Usman

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Checkpoint Inhibitors ◽

Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement

Leukemia & Lymphoma ◽

10.1080/10428190903156745 ◽

2009 ◽

Vol 50 (9) ◽

pp. 1488-1493 ◽

Cited By ~ 10

Author(s):

Heng-Xiang Wang ◽

Hong-Min Yan ◽

Jing Liu ◽

Lian-Ning Duan ◽

Zhi-Dong Wang ◽

...

Keyword(s):

Bone Marrow ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Bone Marrow Involvement ◽

Hematopoietic Stem ◽

Non Hodgkin Lymphoma

The Role of Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma

Cancer Treatment and Research - Hematopoietic Stem Cell Transplantation ◽

10.1007/978-0-387-78580-6_16 ◽

2008 ◽

pp. 399-414

Author(s):

Craig Moskowitz ◽

John Sweetenham

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem Cell Transplantation for Hodgkin Lymphoma

Hematopoietic Cell Transplantation for Malignant Conditions ◽

10.1016/b978-0-323-56802-9.00016-x ◽

2019 ◽

pp. 231-243

Author(s):

Sairah Ahmed

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Feasibility of and Decreased Inpatient Hospital Days for Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL) Patients with Outpatient BEAM Using Daily Etoposide and Cytarabine and Autologous Hematopoietic Stem Cell Transplantation (AHCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.12.712 ◽

2020 ◽

Vol 26 (3) ◽

pp. S159

Author(s):

Kathleen Cavalier ◽

Naomi Cazeau ◽

Valkal Bhatt ◽

Courtney McElrath ◽

Nicole J. LeStrange ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Inpatient Hospital ◽

Non Hodgkin Lymphoma ◽

Hospital Days